Table 1.
Correlation between clinical pathological factors and HABP1 expression
| Variables | No (n = 233) | HABP1 expression | P | |
|---|---|---|---|---|
|
| ||||
| Negative | Positive | |||
| Age | ||||
| < 50 y | 133 | 60 (45.1) | 73 (54.9) | 0.162 |
| ≥ 50 y | 100 | 36 (36) | 64 (64) | |
| Tumor | ||||
| ≤ 2 cm | 68 | 28 (41.2) | 40 (58.8) | 0.996 |
| >2 cm | 165 | 68 (41.2) | 97 (58.8) | |
| LNM | ||||
| Negative | 65 | 34 (52.3) | 31 (47.7) | 0.032 |
| Positive | 168 | 62 (36.9) | 106 (63.1) | |
| Stage | ||||
| I | 26 | 15 (57.7) | 11 (42.3) | 0.041 |
| II | 94 | 43 (45.7) | 51 (54.3) | |
| III | 113 | 38 (33.6) | 75 (66.4) | |
| ER | ||||
| Negative | 135 | 60 (44.4) | 75 (55.6) | 0.238 |
| Positive | 98 | 36 (36.7) | 62 (63.3) | |
| PR | ||||
| Negative | 98 | 44 (44.9) | 54 (55.1) | 0.329 |
| Positive | 135 | 52 (38.5) | 83 (61.5) | |
| HER-2 | ||||
| Negative | 179 | 71 (39.7) | 108 (60.3) | 0.386 |
| Positive | 54 | 25 (46.3) | 29 (53.7) | |
| P53 | ||||
| Negative | 45 | 18 (40) | 27 (60) | 0.855 |
| Positive | 188 | 78 (41.5) | 110 (58.5) | |
| Ki67 | ||||
| < 10% | 68 | 31 (45.6) | 37 (54.4) | 0.382 |
| ≥ 10% | 165 | 65 (39.4) | 100 (60.6) | |
| Molecular classification | ||||
| Luminal-A | 45 | 21 (46.7) | 24 (53.3) | 0.210 |
| Luminal-B | 116 | 40 (34.5) | 76 (65.5) | |
| Her-2(+) | 53 | 25 (47.2) | 28 (52.8) | |
| Triple negative | 19 | 10 (52.6) | 9 (47.4) | |
Chi-square test is used. P-value < 0.05 are considered statistically significant.